Leadership in Challenging Times: Dr. Albert Bourla
Our Privacy Policy has been updated! The Conference Board uses cookies to improve our website, enhance your experience, and deliver relevant messages and offers about our products. Detailed information on the use of cookies on this site is provided in our cookie policy. For more information on how The Conference Board collects and uses personal data, please visit our privacy policy. By continuing to use this Site or by clicking "OK", you acknowledge our privacy policy and consent to the use of cookies. 

SUSTAINING CAPITALISM PODCAST SERIES

Leadership in Challenging Times: Dr. Albert Bourla

Leadership in Challenging Times interviews business leaders about the unprecedented challenges facing the nation

2022 Distinguished Honorees

“Nothing of what was accomplished would have been accomplished without partnerships. In our case, we had to partner with BioNTech…But, we also had to partner with the FDA, and the CDC. […] Without their active collaboration—without [our] active sensing of the way that they worked as well—we wouldn't be able to achieve what we achieved.” So says Dr. Albert Bourla, Chairman and CEO, Pfizer, Inc. in this interview with Dr. Lori Esposito Murray, President of the Committee for Economic Development, the public policy center of The Conference Board (CED).

The CED discussion series, Leadership in Challenging Times, interviews business leaders about the unprecedented challenges facing the nation and how they are helping chart a path forward for both their companies and communities in which they operate. Listen as Dr. Bourla tells Dr. Murray about how Pfizer went about making the “impossible possible” with the development and rollout of the mRNA vaccine, as well as Pfizer’s current efforts to extend health equity to all.

Leadership in Challenging Times: Dr. Albert Bourla

Listen/subscribe on

 

2022 Distinguished Honorees

“Nothing of what was accomplished would have been accomplished without partnerships. In our case, we had to partner with BioNTech…But, we also had to partner with the FDA, and the CDC. […] Without their active collaboration—without [our] active sensing of the way that they worked as well—we wouldn't be able to achieve what we achieved.” So says Dr. Albert Bourla, Chairman and CEO, Pfizer, Inc. in this interview with Dr. Lori Esposito Murray, President of the Committee for Economic Development, the public policy center of The Conference Board (CED).

The CED discussion series, Leadership in Challenging Times, interviews business leaders about the unprecedented challenges facing the nation and how they are helping chart a path forward for both their companies and communities in which they operate. Listen as Dr. Bourla tells Dr. Murray about how Pfizer went about making the “impossible possible” with the development and rollout of the mRNA vaccine, as well as Pfizer’s current efforts to extend health equity to all.

Return to podcast series

Experts in this series

Join experts from The Conference Board as they share Trusted Insights for What’s Ahead™

Dr. Lori Esposito Murray

Dr. Lori Esposito Murray

Senior Fellow for National Security & Managing Dir…
Council on Foreign Relations

Read Bio

Albert Bourla, DVM, PH.D.

Albert Bourla, DVM, PH.D.

Chairman and Chief Executive Officer
Pfizer

Read Bio

Episodes

View more episodes

Other Related Resources

✕
hubCircleImage